Furthermore, the results of our study stand in stark contrast to those of Sundblad et al., an Argentinian group that reported differences in galectin-3 levels between the diffuse and limited subtypes of systemic sclerosis and established a relationship between galectin-3 levels and clinical presentation [16]. Here, LGALS3 is linked to systemic sclerosis.